1171 related articles for article (PubMed ID: 29135993)
1. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation: A Systematic Review and Meta-Analysis.
Tsipotis E; Gupta NR; Raman G; Zintzaras E; Jaber BL
Am J Nephrol; 2016; 44(3):206-18. PubMed ID: 27576318
[TBL] [Abstract][Full Text] [Related]
3. Prograf five milligrams versus Tacrolimus medis in healthy volunteers: a bioequivalence study.
Masri M; Rizk S; Boujbel L; Bellahirich W; Baassoumi D; Attia M; Matha V
Transplant Proc; 2013; 45(10):3453-7. PubMed ID: 24314930
[TBL] [Abstract][Full Text] [Related]
4. Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?
Phillips K; Reddy P; Gabardi S
J Pharm Pract; 2017 Feb; 30(1):9-16. PubMed ID: 26043743
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.
Berg M; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Switzer RD; Privitera MD
JAMA Neurol; 2017 Aug; 74(8):919-926. PubMed ID: 28654954
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of two tacrolimus formulations under fasting conditions in healthy male subjects.
Mathew P; Mandal J; Patel K; Soni K; Tangudu G; Patel R; Kale P
Clin Ther; 2011 Sep; 33(9):1105-19. PubMed ID: 21840601
[TBL] [Abstract][Full Text] [Related]
7. Generic immunosuppressants.
Medeiros M; Lumini J; Stern N; Castañeda-Hernández G; Filler G
Pediatr Nephrol; 2018 Jul; 33(7):1123-1131. PubMed ID: 28733752
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus.
Kovarik JM; Noe A; Wang Y; Mueller I; DeNucci G; Schmouder RL
Eur J Clin Pharmacol; 2006 May; 62(5):361-6. PubMed ID: 16547714
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects.
Almeida S; Filipe A; Neves R; Spínola AC; Tanguay M; Ortuño J; Farré A; Torns A
Clin Ther; 2010 Mar; 32(3):556-74. PubMed ID: 20399993
[TBL] [Abstract][Full Text] [Related]
10. Real-life Bioequivalence of Tacrolimus in Patients With Living-Related Donor De Novo Renal Transplantation: An Observational Study.
Naithani P; Dey S; Attri SV; Patil A; Patial A; Singh S; Panwar R; Sivakumar SP; Singh S; Kenwar DB; Pattanaik S; Sharma A
Transplant Proc; 2020; 52(6):1715-1717. PubMed ID: 32448656
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
12. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
[TBL] [Abstract][Full Text] [Related]
13. Generic tacrolimus in solid organ transplantation.
Taube D; Jones G; O'Beirne J; Wennberg L; Connor A; Rasmussen A; Backman L
Clin Transplant; 2014 May; 28(5):623-32. PubMed ID: 24750309
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial
.
Mohanty L; Bhushan S; Rüttger B
Int J Clin Pharmacol Ther; 2020 Mar; 58(3):183-193. PubMed ID: 31841106
[TBL] [Abstract][Full Text] [Related]
15. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.
Molnar AO; Fergusson D; Tsampalieros AK; Bennett A; Fergusson N; Ramsay T; Knoll GA
BMJ; 2015 Jun; 350():h3163. PubMed ID: 26101226
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the switchability of generic products.
Karalis V; Bialer M; Macheras P
Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
[TBL] [Abstract][Full Text] [Related]
17. Generic lamotrigine extended-release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study.
Fang L; Li Z; Kinjo M; Lomonaco S; Zheng N; Jiang W; Zhao L
Epilepsia; 2023 Jan; 64(1):152-161. PubMed ID: 36259141
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.
Heavner MS; Tichy EM; Yazdi M; Formica RN; Kulkarni S; Emre S
Am J Health Syst Pharm; 2013 Sep; 70(17):1507-12. PubMed ID: 23943182
[TBL] [Abstract][Full Text] [Related]
19. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed.
Robertsen I; Åsberg A; Ingerø AO; Vethe NT; Bremer S; Bergan S; Midtvedt K
Transplantation; 2015 Mar; 99(3):528-32. PubMed ID: 25148382
[TBL] [Abstract][Full Text] [Related]
20. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]